AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

CSL Ltd. Capital/Financing Update 2006

Dec 12, 2006

17854_rns_2006-12-12_d214c149-2fe3-46fb-affa-e9862ea2fe49.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

CSL

Press Release

For immediate release

13 December 2006

Strong Trading Conditions in International Plasma Therapies

CSL Limited today lifted its financial guidance for the 2006/2007 financial year following strong trading conditions in the international plasma therapies market.

The company now expects a net profit after tax of between \$440m and \$460m, an increase of approximately 10% above guidance provided at the 2006 full year result announcement in August of this year.

This revised guidance is subject to currency fluctuation, material price movements in core plasma products and the effective tax rate.

For more information about CSL Limited, visit www.csl.com.au

For further information, please contact: